A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria
Open Access
- 31 July 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15), 8243
- https://doi.org/10.3390/ijms22158243
Abstract
The emergence of multidrug-resistant (MDR) bacteria through the abuse and long-term use of antibiotics is a serious health problem worldwide. Therefore, novel antimicrobial agents that can cure an infection from MDR bacteria, especially gram-negative bacteria, are urgently needed. Antimicrobial peptides, part of the innate immunity system, have been studied to find bactericidal agents potent against MDR bacteria. However, they have many problems, such as restrained systemic activity and cytotoxicity. In a previous study, we suggested that the K58–R78 domain of Romo1, a mitochondrial protein encoded by the nucleus, was a promising treatment candidate for sepsis caused by MDR bacteria. Here, we performed sequence optimization to enhance the antimicrobial activity of this peptide and named it as AMPR-22 (antimicrobial peptide derived from Romo1). It showed broad-spectrum antimicrobial activity against 17 sepsis-causing bacteria, including MDR strains, by inducing membrane permeabilization. Moreover, treatment with AMPR-22 enabled a remarkable survival rate in mice injected with MDR bacteria in a murine model of sepsis. Based on these results, we suggest that AMPR-22 could be prescribed as a first-line therapy (prior to bacterial identification) for patients diagnosed with sepsis.Funding Information
- National Research Foundation of Korea (NRF-2020R1A2C1012207, NRF-2017R1D1A1B03032322)
This publication has 45 references indexed in Scilit:
- A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatmentFrontiers in Pharmacology, 2013
- Designing antimicrobial peptides: form follows functionNature Reviews Drug Discovery, 2011
- Investigating the cationic side chains of the antimicrobial peptide tritrpticin: Hydrogen bonding properties govern its membrane-disruptive activitiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Synthetic therapeutic peptides: science and marketDrug Discovery Today, 2010
- Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magaininBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptidesPeptide Science, 2008
- Effects of Solvent on the Structure of the Alzheimer Amyloid-β(25–35) PeptideBiophysical Journal, 2006
- A novel protein, Romo1, induces ROS production in the mitochondriaBiochemical and Biophysical Research Communications, 2006
- Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2005
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005